Irodalom:
1. Brandi, G., Biavati, B., Calabrese, C.: Urease-positive bacteria other than Helicobacter pylori in human
gastric juice and mucosa. Am Journal of Gastroenterology 2006; 101: 1756-1761
2. Park, C.K., Lee, M.K., Kim, S.W. et al.: When and how should we test Helicobacter pylori infection in
patients with active peptic ulcer bleeding? Gastrointestinal Endoscopy 2006; 63, AB160
3. Graham, D.Y., Hong, L.: Is there a role for sequential in sequential anti-H. pylori therapy?
Gastroenterology 2006; 130: 1930-1931
4. Lassen, A., Hallas, J., Schaffalitzky de Muckadell, O.B.: Complicated and uncomplicated peptic ulcers
104 Gastro Update 2007
in a Danish county 1993-2002: a papulation-based cohort study. Am Journal of Gastroenterology 2006;
101: 945-953
5. Regula, J., Butruk, E., Dekkers, C.P.M. et al.: Prevention of NSAID-associated gastrointestinal lesions:
a comparison study pantoprazole versus omeprazole. Am Journal of Gastroenterology 2006; 101: 1747-1755
6. Thomsen, R.W., Riis, A., Munk, E.M., et al.: 30-day mortality after peptic ulcer perforation among users
of newer selection COX-2 inhibitors and traditional NSAIDs: a population-based study. Am Journal of
Gastroenterology 2006; 101: 2704-2710
7. Yeomans, N.D., Lanas, A., Labenz, J. et al.: Prevention of low dose aspirin-associated gastruduodenal
ulcers and upper gastrointestinal symptoms in patients receiving esomeprazole 20 mg per day.
Gastroenterology 2006; 130: A-81
8. Lee, J.G.: What is the value of early endoscopy in upper gastrointestinal bleeding? Nature Clinical
Practice Gastroenterology & Hepatology 2006; 3 (10): 534-535
9. Carbonell, N., Pauwels, A., Serfaty, L. et al.: Erythromycin infusion prior to endoscopy for acute upper
gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am Journal of Gastroenterology
2006; 101: 1211-1215
10. Dorward, S., Sreedharan, A., Leontiadis, G.I. et al.: Proton pump inhibitor treatment initiated prior to
endoscopic diagnosis in unselected upper gastrointestinal bleeding. A Cochrane systematic review and
meta-analysis. Gastroenterology 2006; 130: A-122
11. Chiu, P.W., Joeng, H., Choi, C. et al.: The effect of scheduled second endoscopy against intravenous
high dose omeprazole infusion as an adjunct to therapeutic endoscopy in prevention of peptic ulcer
rebleeding — a prospective randomized study. Gastroenterology 2006; 130: A-121
12. Quentin, V., Dib, N., Thouveny, F. et al.: Chronic ischemic gastritis: case report of a difficult diagnosis
and review of the literature. Endoscopy 2006; 38 (5): 529-532
13. Heidelbaugh, J.J., Inadomi, J.M.: Magnitude and economic impact of inappropriate use of stress ulcer
prophylaxis in non-ICU hospitalized patients. Am Journal of Gastroenterology 2006; 101: 2200-2205
14. Gardner T.B., Robertson D.J.: Stress ulcer prophylaxis in non-critically ill patients: Less may be more?
Am Journal of Gastroenterology 2006; 101: 2206-2208
15. Karamonolis, G., Caenepeel, P., Arts, J. et al.: Association of the predominant symptom with clinical
characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006;
130: 296-303
16. Jarbol, D.E., Kragstrup, J., Stovring, H. et al.: Proton pump inhibitor or testing for Helicobacter pylori
as the first step for patients presenting with dyspepsia? A cluster-randomized trial. Am Journal of
Gastroenterology 2006; 101: 1200-1208
17. Bytzer, P.: Management of the dyspeptic patient: anything goes? Am Journal of Gastroenterology 2006;
101: 1209-1210
18. Kerhoven, L.A.S., Rossum, L.G.M., Oijen, M.G.H. et al.: Upper gastrointestinal endoscopy does not
reassure patients with functional dyspepsia. Endoscopy 2006; 38: 879-885
19. Park, M.I., Camilleri, M.: Gastroparesis: clinical update. Am Journal of Gastroenterology 2006; 101:
1129-1139
20. Lau, M., Le, A., El-Serag, H.B.: Noncardia gastric adenocarcinoma remains an important and deadly
cancer int he United States: secular trends in incidence and survival. Am Journal of Gastroenterology
2006; 101: 2485-2492
21. You, W.C., Brown, L.M., Zhang L. et al.: Randomized double-blind factorial trial of three treat ments to
reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974-983
22. Genta, R.M., Pusztaszeri, M.: The gastric mucosa in gastric cancer patients in a low-incidence area.
European Journal of Gastroenterology & Hepatology 2006; 18:1085-1093
23. Rodríguez, L.A.G., Lagergren, J., Lindblad, M.: Gastric acid suppression and risk of oesophageal
A gyomor 105
and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006; 55: 1538-1544
24. Naylor, G.M., Gotoda, T., Dixon, M. et al.: Why does Japan have a high incidence of gastric
cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006; 55: 1545-1552
25. Liu, F., Pan, K., Zhang, X. et al.: Genetic variants in cyclooxygenase-2: expression and risk of gastric
cancer and its precursors in a Chinese population. Gastroenterology 2006; 130: 1975-1984
